The cerebellum plays a crucial role in cognitive processing, making it a potential target for therapeutic intervention in Alzheimer's disease (AD).
Objective
This study aimed to investigate the effect of cerebellar intermittent theta-burst stimulation (iTBS) in patients with AD.
Methods
We conducted a randomized, double-blind, sham-controlled clinical trial in which patients were randomly allocated to receive either active-iTBS or sham-iTBS. The primary outcome was the change in Clinical Dementia Rating Scale Sum of Boxes (CDR-SB) scores from baseline to week 4. Secondary outcomes included evaluations of neurophysiological measures, brain network functions, and glymphatic clearance.
Results
From April 20 to June 25, 2024, 20 patients were analyzed. Compared with sham-iTBS, active-iTBS significantly improved cognition at week 4, indicated by reduced CDR-SB scores (mean changes: −0.60 versus 0.15; adjusted β: 0.73; 95% CI, 0.17–1.26). In the active-iTBS group compared with the sham-iTBS group, the power spectral density in electroencephalogram revealed global decreased in theta power (adjusted β, −0.014; 95% CI, −0.024–0.003) and increased beta power (adjusted β, 0.002; 95%CI, 0.000–0.005), the functional magnetic resonance imaging demonstrated enhanced the gradient values of default mode network activity along the principal gradient, and the structural magnetic resonance imaging indicated an improvement in glymphatic clearance (adjusted β, 0.097, 95% CI, 0.0381–0.1603).
Conclusions
A four-week course of iTBS improved cognitive function in patients with AD, possibly via promoting the Beta frequency band power, enhancing brain network functionality, and facilitating glymphatic clearance.
ScheltensPDe StrooperBKivipeltoM, et al.Alzheimer's disease. Lancet2021; 397: 1577–1590.
2.
BriggsRKennellySPO'NeillD. Drug treatments in Alzheimer's disease. Clin Med (Lond)2016; 16: 247–253.
3.
KhanSBarveKHKumarMS. Recent advancements in pathogenesis, diagnostics and treatment of Alzheimer's disease. Curr Neuropharmacol2020; 18: 1106–1125.
4.
van DyckCHSwansonCJAisenP, et al.Lecanemab in early Alzheimer's disease. N Engl J Med2023; 388: 9–21.
5.
PasseriEElkhouryKMorsinkM, et al.Alzheimer's disease: treatment strategies and their limitations. Int J Mol Sci2022; 23: 13954.
6.
CummingsJLTongGBallardC. Treatment combinations for Alzheimer's disease: current and future pharmacotherapy options. J Alzheimers Dis2019; 67: 779–794.
7.
KochGCasulaEPBonnìS, et al.Precuneus magnetic stimulation for Alzheimer's disease: a randomized, sham-controlled trial. Brain2022; 145: 3776–3786.
8.
SabbaghMSadowskyCTousiB, et al.Effects of a combined transcranial magnetic stimulation (TMS) and cognitive training intervention in patients with Alzheimer's disease. Alzheimers Dement2020; 16: 641–650.
9.
MoussaviZUeharaMRutherfordG, et al.Repetitive transcranial magnetic stimulation as a treatment for Alzheimer's disease: a randomized placebo-controlled double-blind clinical trial. Neurotherapeutics2024; 21: e00331.
10.
LiXQiGYuC, et al.Cortical plasticity is correlated with cognitive improvement in Alzheimer's disease patients after rTMS treatment. Brain Stimul2021; 14: 503–510.
11.
YaoQTangFWangY, et al.Effect of cerebellum stimulation on cognitive recovery in patients with Alzheimer disease: a randomized clinical trial. Brain Stimul2022; 15: 910–920.
12.
DicksonPECairnsJGoldowitzD, et al.Cerebellar contribution to higher and lower order rule learning and cognitive flexibility in mice. Neuroscience2017; 345: 99–109.
13.
Starowicz-FilipAChrobakAAMoskałaM, et al.The role of the cerebellum in the regulation of language functions. Psychiatr Pol2017; 51: 661–671.
14.
SchmahmannJD. The cerebellum and cognition. Neurosci Lett2019; 688: 62–75.
15.
BucknerRL. The cerebellum and cognitive function: 25 years of insight from anatomy and neuroimaging. Neuron2013; 80: 807–815.
16.
ZhangPDuanLOuY, et al.The cerebellum and cognitive neural networks. Front Hum Neurosci2023; 17: 1197459.
17.
MariënPAckermannHAdamaszekM, et al.Consensus paper: language and the cerebellum: an ongoing enigma. Cerebellum2014; 13: 386–410.
18.
LeggioMOlivitoG. Topography of the cerebellum in relation to social brain regions and emotions. Handb Clin Neurol2018; 154: 71–84.
19.
ChanHHHogueOMathewsND, et al.Deep cerebellar stimulation enhances cognitive recovery after prefrontal traumatic brain injury in rodent. Exp Neurol2022; 355: 114136.
20.
MitomaHBuffoAGelfoF, et al.Consensus Paper. Cerebellar reserve: from cerebellar physiology to cerebellar disorders. Cerebellum2020; 19: 131–153.
21.
JacobsHILHopkinsDAMayrhoferHC, et al.The cerebellum in Alzheimer's disease: evaluating its role in cognitive decline. Brain2018; 141: 37–47.
22.
TangFZhuDMaW, et al.Differences changes in cerebellar functional connectivity between mild cognitive impairment and Alzheimer's disease: a seed-based approach. Front Neurol2021; 12: 645171.
23.
JackCRBennettDABlennowK, et al.NIA-AA research framework: toward a biological definition of Alzheimer's disease. Alzheimers Dement2018; 14: 535–562.
24.
McKhannGMKnopmanDSChertkowH, et al.The diagnosis of dementia due to Alzheimer's disease: recommendations from the national institute on aging-Alzheimer's association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement2011; 7: 263–269.
25.
JalalvandARRoushaniMGoicoecheaHC, et al.MATLAB In electrochemistry: a review. Talanta2019; 194: 205–225.
26.
ZhangJCaiXWangY, et al.Different brain activation after acupuncture at combined acupoints and single acupoint in hypertension patients: an rs-fMRI study based on ReHo analysis. Evid Based Complement Alternat Med2019; 2019: 5262896.
27.
XuXLiWTaoM, et al.Effective and accurate diagnosis of subjective cognitive decline based on functional connection and graph theory view. Front Neurosci2020; 14: 577887.
28.
ZhongYHuangLCaiS, et al.Altered effective connectivity patterns of the default mode network in Alzheimer's disease: an fMRI study. Neurosci Lett2014; 578: 171–175.
29.
TaokaTItoRNakamichiR, et al.Diffusion Tensor Image Analysis ALong the Perivascular Space (DTI-ALPS): revisiting the meaning and significance of the method. Magn Reson Med Sci2024; 23: 268–290.
30.
ZhangJLiuSWuY, et al.Enlarged perivascular space and index for diffusivity along the perivascular space as emerging neuroimaging biomarkers of neurological diseases. Cell Mol Neurobiol2023; 44: 14.
31.
FischlB. Freesurfer. Neuroimage2012; 62: 774–781.
32.
UmemuraYWatanabeKKasaiS, et al.Choroid plexus enlargement in mild cognitive impairment on MRI: a large cohort study. Eur Radiol2024; 34: 5297–5304.
33.
LefaucheurJPAlemanABaekenC, et al.Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS): an update (2014-2018). Clin Neurophysiol2020; 131: 474–528.
34.
ZhangFQinYXieL, et al.High-frequency repetitive transcranial magnetic stimulation combined with cognitive training improves cognitive function and cortical metabolic ratios in Alzheimer's disease. J Neural Transm (Vienna)2019; 126: 1081–1094.
35.
PezzettaRGambarotaFTarantinoV, et al.A meta-analysis of non-invasive brain stimulation (NIBS) effects on cerebellar-associated cognitive processes. Neurosci Biobehav Rev2024; 157: 105509.
36.
WuXJiGJGengZ, et al.Accelerated intermittent theta-burst stimulation broadly ameliorates symptoms and cognition in Alzheimer's disease: a randomized controlled trial. Brain Stimul2022; 15: 35–45.
37.
SpinelliGBakardjianHSchwartzD, et al.Theta band-power shapes amyloid-driven longitudinal EEG changes in elderly subjective memory complainers at-risk for Alzheimer's disease. J Alzheimers Dis2022; 90: 69–84.
38.
SimfukweCHanSHJeongHT, et al.qEEG as biomarker for Alzheimer's disease: investigating relative PSD difference and coherence analysis. Neuropsychiatr Dis Treat2023; 19: 2423–2437.
39.
GoutagnyRGuNCavanaghC, et al.Alterations in hippocampal network oscillations and theta-gamma coupling arise before Aβ overproduction in a mouse model of Alzheimer's disease. Eur J Neurosci2013; 37: 1896–1902.
40.
ChristidiFKaravasilisERentzosM, et al.Hippocampal pathology in amyotrophic lateral sclerosis: selective vulnerability of subfields and their associated projections. Neurobiol Aging2019; 84: 178–188.
41.
PumaSMattonNPaubelPV, et al.Using theta and alpha band power to assess cognitive workload in multitasking environments. Int J Psychophysiol2018; 123: 111–120.
42.
ScheltensPHallikainenMGrimmerT, et al.Safety, tolerability and efficacy of the glutaminyl cyclase inhibitor PQ912 in Alzheimer's disease: results of a randomized, double-blind, placebo-controlled phase 2a study. Alzheimers Res Ther2018; 10: 107.
43.
AzamiHZrennerCBrooksH, et al.Beta to theta power ratio in EEG periodic components as a potential biomarker in mild cognitive impairment and Alzheimer's dementia. Alzheimers Res Ther2023; 15: 133.
44.
BaikKJungJHJeongSH, et al.Implication of EEG theta/alpha and theta/beta ratio in Alzheimer's and Lewy body disease. Sci Rep2022; 12: 18706.
45.
LinHLiangJWangQ, et al.Effects of accelerated intermittent theta-burst stimulation in modulating brain of Alzheimer's disease. Cereb Cortex2024; 34: bhae106.
46.
LiangKJCarlsonES. Resistance, vulnerability and resilience: a review of the cognitive cerebellum in aging and neurodegenerative diseases. Neurobiol Learn Mem2020; 170: 106981.
47.
ArleoABarešMBernardJA, et al.Consensus paper: cerebellum and ageing. Cerebellum2023; 23: 802–832.
48.
HabasC. Functional connectivity of the cognitive cerebellum. Front Syst Neurosci2021; 15: 642225.
49.
OlivitoGSerraLMarraC, et al.Cerebellar dentate nucleus functional connectivity with cerebral cortex in Alzheimer's disease and memory: a seed-based approach. Neurobiol Aging2020; 89: 32–40.
50.
BernardJAPeltierSJBensonBL, et al.Dissociable functional networks of the human dentate nucleus. Cereb Cortex2014; 24: 2151–2159.
51.
GuellXD'MelloAMHubbardNA, et al.Functional territories of human dentate nucleus. Cereb Cortex2020; 30: 2401–2417.
52.
VipinALokeYMLiuS, et al.Cerebrovascular disease influences functional and structural network connectivity in patients with amnestic mild cognitive impairment and Alzheimer's disease. Alzheimers Res Ther2018; 10: 82.
53.
ZhouJGreiciusMDGennatasED, et al.Divergent network connectivity changes in behavioural variant frontotemporal dementia and Alzheimer's disease. Brain2010; 133: 1352–1367.
54.
QianSZhangZLiB, et al.Functional-structural degeneration in dorsal and ventral attention systems for Alzheimer's disease, amnestic mild cognitive impairment. Brain Imaging Behav2015; 9: 790–800.
55.
ZhaoQLuHMetmerH, et al.Evaluating functional connectivity of executive control network and frontoparietal network in Alzheimer's disease. Brain Res2018; 1678: 262–272.
56.
HeYLiQFuZ, et al.Functional gradients reveal altered functional segregation in patients with amnestic mild cognitive impairment and Alzheimer's disease. Cereb Cortex2023; 33: 10836–10847.
57.
HuQLiYWuY, et al.Brain network hierarchy reorganization in Alzheimer's disease: a resting-state functional magnetic resonance imaging study. Hum Brain Mapp2022; 43: 3498–3507.
58.
SunBLWangLHYangT, et al.Lymphatic drainage system of the brain: a novel target for intervention of neurological diseases. Prog Neurobiol2018; 163-164: 118–143.
59.
Da MesquitaSPapadopoulosZDykstraT, et al.Meningeal lymphatics affect microglia responses and anti-Aβ immunotherapy. Nature2021; 593: 255–260.
60.
Da MesquitaSLouveauAVaccariA, et al.Functional aspects of meningeal lymphatics in ageing and Alzheimer's disease. Nature2018; 560: 185–191.
61.
YamadaKIwatsuboT. Involvement of the glymphatic/meningeal lymphatic system in Alzheimer's disease: insights into proteostasis and future directions. Cell Mol Life Sci2024; 81: 192.
62.
LiYWangLZhongJ, et al.Impaired glymphatic function as a biomarker for subjective cognitive decline: an exploratory dual cohort study. Alzheimers Dement2024; 20: 6542–6555.
63.
ChachajAGąsiorowskiKSzubaA, et al.The lymphatic system in the brain clearance mechanisms - new therapeutic perspectives for Alzheimer's disease. Curr Neuropharmacol2023; 21: 380–391.
64.
HuangSYZhangYRGuoY, et al.Glymphatic system dysfunction predicts amyloid deposition, neurodegeneration, and clinical progression in Alzheimer's disease. Alzheimers Dement2024; 20: 3251–3269.
65.
LinYJinJLvR, et al.Repetitive transcranial magnetic stimulation increases the brain's drainage efficiency in a mouse model of Alzheimer's disease. Acta Neuropathol Commun2021; 9: 102.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
